AAMC CHARGE cultivates the health equity community by advancing collaborative research, policy, and programmatic solutions to health and health care inequities.
The vision of AAMC CHARGE is an equitable and just society in which academic health centers:
- Prioritize health equity scholarship and research across the full spectrum of scientific inquiry.
- Partner with communities, families, and patients to develop solutions to health injustice.
- Advocate for structural changes that address the root causes of health inequities.
AAMC CHARGE participants:
- Share accomplishments and crowdsource opportunities for professional achievement.
- Facilitate innovative multi-sector partnerships, collaborations, and research that contribute to the evidence base for solutions to health and health care inequities.
- Collaborate on policy work that impacts health equity at institutional, local, state, and federal levels.
Join AAMC CHARGE
Join AAMC CHARGE and connect with a vibrant community of health equity researchers and community partners. CHARGE participants receive alerts to new collaboration and advocacy opportunities, our monthly newsletter, AAMC Health Equity Research and Policy Update, and are invited to participate in the group’s online virtual community.
AAMC Center for Health Justice Roadshow: Part One
Thursday, May 6, 2021
1-2 p.m. ET
On Thursday, May 6, join AAMC CHARGE for a three-part roadshow series about the AAMC Center for Health Justice, launching later in 2021 as one part of the AAMC's Strategic Plan. We'll discuss the role of AAMC CHARGE in guiding the Center and how you can get involved. Mark your calendars!
- Thursday, May 6, 1-2 p.m. ET
- Tuesday, June 8, 2021, 3-4 p.m. ET
- Wednesday, July 7, 2021, 6-7 p.m. ET
The first roadshow will provide an overview of what to expect for the soft launch of the Center this spring. We’ll also be announcing a very exciting opportunity for AAMC CHARGE participants. See you there!
BMSF Diversity in Clinical Trials Career Development Program
The Bristol Myers Squibb Foundation (BMSF) Diversity in Clinical Trials Career Development Program is a 2-year initiative designed to foster independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring. In this webinar, representatives from the program answered questions for potential applicants, and collected expertise from AAMC CHARGE on best practices to train fellows in bidirectional, multi-sector community-engaged research. Applications for the program are due July 2.
Our Latest Policy and Advocacy Work
On April 9, 2021, the AAMC submitted comments to the National Institutes of Health (NIH) in response to a Request for Information on strengthening racial equity, diversity, and inclusion in the biomedical research workforce, and advancing health equity and health disparities research. The letter proposed strategies to improve representation and reduce barriers for a diverse workforce, and noted the importance of a multi-sector approach to health disparities research.
On January 14, 2021, the AAMC submitted comments to the National Institute of Mental Health (NIMH) on research priorities for the prevention of Black youth suicide. The AAMC encouraged the NIMH to fund multi-sector research that engages youth, families, and communities to reimagine school-based interventions and develop culturally appropriate, holistic behavioral health supports.
On May 29, 2020, the AAMC submitted comments to the Centers for Medicare and Medicaid Services (CMS) on rural maternal health disparities. In its comments, the AAMC encouraged CMS to leverage existing federal partnerships, partner with community-based stakeholders to address systemic issues, and invest in alternative care models.
On March 27, 2020, the AAMC submitted a response to a request for Stakeholder Input on Opportunities for Increased Collaboration to Advance Prevention Research from the National Institutes of Health (NIH) Office of Disease Prevention (ODP). The AAMC recommended ODP formalize its connections with nonprofit hospitals' population health efforts, and engage with other prevention and translational research programs and sites.
On February 25, 2020, the AAMC submitted comments to the Food and Drug Administration (FDA) on the development of strategic priorities for the Office of Minority Health and Health Equity (OMHHE). The AAMC recommended that the FDA and OMHHE collaborate and align research and communication practices across local, regional, and national, and minority organizations.
On February 21, 2020, the AAMC submitted comments to the National Institutes of Health (NIH) on its Proposed Research Initiative to Decrease Maternal Mortality. The AAMC urged the NIH to "identify evidence-based solutions which are translatable, effective, and can address the multiple health needs of mothers burdened by this crisis" through increased funding, alternative care models, and community engagement.
On February 3, 2020, the AAMC submitted comments to the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health on the social determinant of health (SDOH) measures proposed for inclusion in the Consensus Measures for Phenotypes and Exposures (PhenX) Toolkit. The AAMC recommended separate measures for community-level SDOH, individual-level, and health-related social needs (HRSN); measures that are accessible to, and useful for, measurement across diverse communities; and guidance concerning the ethical imperative researchers may have to refer participants who screen positive for serious HRSN and SDOH.
On October 25, 2019 the AAMC responded to a request for information from the National Center for Advancing Translational Sciences (NCATS) on improvements to the Clinical and Translational Science Awards (CTSA) Program: "The AAMC encourages NCATS to increase community engagement (CE)-focused funding to allow the CE cores to develop into “CE hubs” tasked, in part, with weaving together community- and patient-engaged efforts across the research, clinical, and training missions of their institutions."
On August 12, 2019 the AAMC submitted a comment letter to the HHS’ Office of Civil Rights that called for the withdrawal of its proposed changes to Section 1557 regulations because if the proposal is finalized it would eliminate all protections for transgender Americans as well as some for those with limited English proficiency. Section 1557 is intended to provide individuals with broad protections, ensuring that “an individual shall not . . . be excluded from participation in, be denied the benefits of, or be subject to discrimination under, any health care program or activity that is administered by an Executive Agency or any entity established under this title…”.
On August 6, 2019 the AAMC sent a letter to the Food and Drug Administration (PDF) on the agency’s request for information regarding the draft guidance Enhancing the Diversity of Clinical Trial Populations-Eligibility Criteria, Enrollment Practices, and Trial Designs. The AAMC offered comments regarding ways to broaden clinical trial eligibility requirements, improve clinical trial enrollment and retention, and use community engagement methods to increase patient participation.
On August 5, 2019 the AAMC sent a letter to the Office of Science and Technology Policy (OSTP) (PDF) to inform the development of the National Research Strategy for the President’s Roadmap to Empower Veterans and End the National Tragedy of Suicide. AAMC offered recommendations to improve the ability to identify individual veterans and groups of veterans at greater risk of suicide and to develop public-private collaboration models to foster innovative and effective research.